nodes	percent_of_prediction	percent_of_DWPC	metapath
Nefazodone—SLC6A3—bipolar disorder	0.201	0.244	CbGaD
Nefazodone—HTR2C—bipolar disorder	0.181	0.22	CbGaD
Nefazodone—HTR1A—bipolar disorder	0.176	0.214	CbGaD
Nefazodone—SLC6A4—bipolar disorder	0.15	0.182	CbGaD
Nefazodone—HTR2A—bipolar disorder	0.115	0.14	CbGaD
Nefazodone—SLC6A2—locus ceruleus—bipolar disorder	0.00792	0.123	CbGeAlD
Nefazodone—HTR2A—locus ceruleus—bipolar disorder	0.00476	0.0738	CbGeAlD
Nefazodone—SLC6A3—telencephalic ventricle—bipolar disorder	0.00465	0.0722	CbGeAlD
Nefazodone—HTR2C—telencephalic ventricle—bipolar disorder	0.0045	0.0698	CbGeAlD
Nefazodone—SLC6A2—autonomic nervous system—bipolar disorder	0.00421	0.0652	CbGeAlD
Nefazodone—HTR1A—telencephalic ventricle—bipolar disorder	0.00379	0.0587	CbGeAlD
Nefazodone—HTR2A—autonomic nervous system—bipolar disorder	0.00253	0.0392	CbGeAlD
Nefazodone—HTR2A—telencephalic ventricle—bipolar disorder	0.00226	0.035	CbGeAlD
Nefazodone—HTR2A—urine—bipolar disorder	0.00206	0.032	CbGeAlD
Nefazodone—SLC6A4—blood plasma—bipolar disorder	0.00203	0.0315	CbGeAlD
Nefazodone—CYP3A4—urine—bipolar disorder	0.00191	0.0296	CbGeAlD
Nefazodone—CYP2D6—urine—bipolar disorder	0.00188	0.0291	CbGeAlD
Nefazodone—HTR1A—blood plasma—bipolar disorder	0.00181	0.028	CbGeAlD
Nefazodone—CYP3A5—blood plasma—bipolar disorder	0.00133	0.0206	CbGeAlD
Nefazodone—ADRA2A—blood plasma—bipolar disorder	0.00127	0.0196	CbGeAlD
Nefazodone—HTR2A—blood plasma—bipolar disorder	0.00108	0.0167	CbGeAlD
Nefazodone—CYP3A4—blood plasma—bipolar disorder	0.000996	0.0154	CbGeAlD
Nefazodone—CYP2D6—blood plasma—bipolar disorder	0.00098	0.0152	CbGeAlD
Nefazodone—ADRA1B—nervous system—bipolar disorder	0.000881	0.0137	CbGeAlD
Nefazodone—ABCB1—blood plasma—bipolar disorder	0.000705	0.0109	CbGeAlD
Nefazodone—ADRA1B—brain—bipolar disorder	0.000673	0.0104	CbGeAlD
Nefazodone—SLC6A3—nervous system—bipolar disorder	0.00066	0.0102	CbGeAlD
Nefazodone—HTR2C—nervous system—bipolar disorder	0.000638	0.00989	CbGeAlD
Nefazodone—SLC6A3—cerebellum—bipolar disorder	0.000621	0.00963	CbGeAlD
Nefazodone—SLC6A4—nervous system—bipolar disorder	0.000605	0.00937	CbGeAlD
Nefazodone—HTR1A—nervous system—bipolar disorder	0.000537	0.00832	CbGeAlD
Nefazodone—SLC6A2—nervous system—bipolar disorder	0.000532	0.00825	CbGeAlD
Nefazodone—HTR1A—cerebellum—bipolar disorder	0.000505	0.00783	CbGeAlD
Nefazodone—SLC6A3—brain—bipolar disorder	0.000504	0.00782	CbGeAlD
Nefazodone—ADRA1A—nervous system—bipolar disorder	0.000495	0.00767	CbGeAlD
Nefazodone—Zuclopenthixol—DRD5—bipolar disorder	0.000492	0.0609	CrCbGaD
Nefazodone—HTR2C—brain—bipolar disorder	0.000488	0.00756	CbGeAlD
Nefazodone—ADRA1A—cerebellum—bipolar disorder	0.000466	0.00722	CbGeAlD
Nefazodone—SLC6A4—brain—bipolar disorder	0.000462	0.00717	CbGeAlD
Nefazodone—Aripiprazole—DRD5—bipolar disorder	0.000454	0.0563	CrCbGaD
Nefazodone—ADRA2A—thyroid gland—bipolar disorder	0.000447	0.00694	CbGeAlD
Nefazodone—HTR1A—brain—bipolar disorder	0.00041	0.00636	CbGeAlD
Nefazodone—SLC6A2—brain—bipolar disorder	0.000407	0.00631	CbGeAlD
Nefazodone—ADRA1A—brain—bipolar disorder	0.000378	0.00586	CbGeAlD
Nefazodone—ADRA2A—nervous system—bipolar disorder	0.000376	0.00583	CbGeAlD
Nefazodone—ABCB1—adrenal cortex—bipolar disorder	0.000358	0.00555	CbGeAlD
Nefazodone—ADRA2A—cerebellum—bipolar disorder	0.000354	0.00549	CbGeAlD
Nefazodone—Acetophenazine—DRD1—bipolar disorder	0.000336	0.0416	CrCbGaD
Nefazodone—HTR2A—nervous system—bipolar disorder	0.00032	0.00496	CbGeAlD
Nefazodone—HTR2A—cerebellum—bipolar disorder	0.000301	0.00467	CbGeAlD
Nefazodone—CYP3A4—nervous system—bipolar disorder	0.000296	0.00459	CbGeAlD
Nefazodone—CYP2D6—nervous system—bipolar disorder	0.000291	0.00452	CbGeAlD
Nefazodone—ADRA2A—brain—bipolar disorder	0.000288	0.00446	CbGeAlD
Nefazodone—Quetiapine—DRD5—bipolar disorder	0.000284	0.0352	CrCbGaD
Nefazodone—CYP2D6—cerebellum—bipolar disorder	0.000274	0.00425	CbGeAlD
Nefazodone—Domperidone—DRD3—bipolar disorder	0.00026	0.0321	CrCbGaD
Nefazodone—ABCB1—thyroid gland—bipolar disorder	0.000249	0.00386	CbGeAlD
Nefazodone—HTR2A—brain—bipolar disorder	0.000245	0.00379	CbGeAlD
Nefazodone—Acetophenazine—DRD2—bipolar disorder	0.000237	0.0294	CrCbGaD
Nefazodone—Aripiprazole—DRD4—bipolar disorder	0.000232	0.0288	CrCbGaD
Nefazodone—CYP2D6—brain—bipolar disorder	0.000223	0.00345	CbGeAlD
Nefazodone—Zuclopenthixol—DRD1—bipolar disorder	0.000213	0.0264	CrCbGaD
Nefazodone—ABCB1—nervous system—bipolar disorder	0.00021	0.00325	CbGeAlD
Nefazodone—Aripiprazole—DRD3—bipolar disorder	0.0002	0.0248	CrCbGaD
Nefazodone—ABCB1—cerebellum—bipolar disorder	0.000197	0.00306	CbGeAlD
Nefazodone—Aripiprazole—DRD1—bipolar disorder	0.000197	0.0244	CrCbGaD
Nefazodone—Thioproperazine—DRD1—bipolar disorder	0.000187	0.0231	CrCbGaD
Nefazodone—Domperidone—DRD2—bipolar disorder	0.00018	0.0222	CrCbGaD
Nefazodone—Prochlorperazine—DRD3—bipolar disorder	0.000179	0.0221	CrCbGaD
Nefazodone—Aripiprazole—HTR2C—bipolar disorder	0.000168	0.0208	CrCbGaD
Nefazodone—Trazodone—HTR2C—bipolar disorder	0.000168	0.0207	CrCbGaD
Nefazodone—Aripiprazole—HTR1A—bipolar disorder	0.000163	0.0202	CrCbGaD
Nefazodone—Trazodone—HTR1A—bipolar disorder	0.000163	0.0201	CrCbGaD
Nefazodone—Fluphenazine—DRD3—bipolar disorder	0.000162	0.02	CrCbGaD
Nefazodone—ABCB1—brain—bipolar disorder	0.00016	0.00248	CbGeAlD
Nefazodone—Fluphenazine—DRD1—bipolar disorder	0.000159	0.0196	CrCbGaD
Nefazodone—Thioproperazine—HTR1A—bipolar disorder	0.000155	0.0192	CrCbGaD
Nefazodone—Zuclopenthixol—DRD2—bipolar disorder	0.00015	0.0186	CrCbGaD
Nefazodone—Prochlorperazine—HTR2C—bipolar disorder	0.00015	0.0186	CrCbGaD
Nefazodone—Quetiapine—DRD4—bipolar disorder	0.000145	0.018	CrCbGaD
Nefazodone—Aripiprazole—SLC6A4—bipolar disorder	0.000139	0.0173	CrCbGaD
Nefazodone—Trazodone—SLC6A4—bipolar disorder	0.000139	0.0172	CrCbGaD
Nefazodone—Aripiprazole—DRD2—bipolar disorder	0.000139	0.0172	CrCbGaD
Nefazodone—Fluphenazine—HTR2C—bipolar disorder	0.000136	0.0168	CrCbGaD
Nefazodone—Fluphenazine—HTR1A—bipolar disorder	0.000132	0.0163	CrCbGaD
Nefazodone—Thioproperazine—DRD2—bipolar disorder	0.000132	0.0163	CrCbGaD
Nefazodone—Perphenazine—DRD1—bipolar disorder	0.000125	0.0155	CrCbGaD
Nefazodone—Quetiapine—DRD3—bipolar disorder	0.000125	0.0155	CrCbGaD
Nefazodone—Prochlorperazine—DRD2—bipolar disorder	0.000124	0.0153	CrCbGaD
Nefazodone—Quetiapine—DRD1—bipolar disorder	0.000123	0.0152	CrCbGaD
Nefazodone—Zuclopenthixol—HTR2A—bipolar disorder	0.000116	0.0144	CrCbGaD
Nefazodone—Fluphenazine—DRD2—bipolar disorder	0.000112	0.0138	CrCbGaD
Nefazodone—Trifluoperazine—HTR2C—bipolar disorder	0.000108	0.0134	CrCbGaD
Nefazodone—Perphenazine—HTR2C—bipolar disorder	0.000107	0.0133	CrCbGaD
Nefazodone—Aripiprazole—HTR2A—bipolar disorder	0.000107	0.0133	CrCbGaD
Nefazodone—Trazodone—HTR2A—bipolar disorder	0.000107	0.0132	CrCbGaD
Nefazodone—Trifluoperazine—HTR1A—bipolar disorder	0.000105	0.013	CrCbGaD
Nefazodone—Quetiapine—HTR2C—bipolar disorder	0.000105	0.013	CrCbGaD
Nefazodone—Perphenazine—HTR1A—bipolar disorder	0.000104	0.0129	CrCbGaD
Nefazodone—Quetiapine—HTR1A—bipolar disorder	0.000102	0.0126	CrCbGaD
Nefazodone—Thioproperazine—HTR2A—bipolar disorder	0.000102	0.0126	CrCbGaD
Nefazodone—Trifluoperazine—DRD2—bipolar disorder	8.94e-05	0.0111	CrCbGaD
Nefazodone—Perphenazine—DRD2—bipolar disorder	8.84e-05	0.0109	CrCbGaD
Nefazodone—Quetiapine—DRD2—bipolar disorder	8.67e-05	0.0107	CrCbGaD
Nefazodone—Fluphenazine—HTR2A—bipolar disorder	8.64e-05	0.0107	CrCbGaD
Nefazodone—Trifluoperazine—HTR2A—bipolar disorder	6.91e-05	0.00855	CrCbGaD
Nefazodone—Perphenazine—HTR2A—bipolar disorder	6.83e-05	0.00846	CrCbGaD
Nefazodone—Quetiapine—HTR2A—bipolar disorder	6.7e-05	0.0083	CrCbGaD
Nefazodone—ADRA2A—GPCR ligand binding—POMC—bipolar disorder	1.91e-05	0.000182	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—ADCY2—bipolar disorder	1.9e-05	0.000181	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—DRD2—bipolar disorder	1.88e-05	0.00018	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—DRD4—bipolar disorder	1.88e-05	0.000179	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—PDE4B—bipolar disorder	1.88e-05	0.000179	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—TACR1—bipolar disorder	1.88e-05	0.000179	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—TSHB—bipolar disorder	1.88e-05	0.000179	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—TSHB—bipolar disorder	1.87e-05	0.000178	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—PDE4B—bipolar disorder	1.87e-05	0.000178	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—TACR1—bipolar disorder	1.87e-05	0.000178	CbGpPWpGaD
Nefazodone—ABCB1—Transmembrane transport of small molecules—SLC6A3—bipolar disorder	1.86e-05	0.000177	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—NR1D1—bipolar disorder	1.85e-05	0.000176	CbGpPWpGaD
Nefazodone—ABCB1—Transmembrane transport of small molecules—ADCY2—bipolar disorder	1.84e-05	0.000176	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—ADM—bipolar disorder	1.84e-05	0.000175	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—CLOCK—bipolar disorder	1.81e-05	0.000173	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—SNAP25—bipolar disorder	1.79e-05	0.000171	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—TSHB—bipolar disorder	1.79e-05	0.000171	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—PDE4B—bipolar disorder	1.79e-05	0.000171	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—TACR1—bipolar disorder	1.79e-05	0.000171	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—NCAN—bipolar disorder	1.77e-05	0.000169	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—ADCY2—bipolar disorder	1.77e-05	0.000169	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—TSHB—bipolar disorder	1.77e-05	0.000168	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—TPH2—bipolar disorder	1.77e-05	0.000168	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—CACNB2—bipolar disorder	1.77e-05	0.000168	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—DRD2—bipolar disorder	1.75e-05	0.000167	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—TRPC3—bipolar disorder	1.75e-05	0.000166	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—NR1D1—bipolar disorder	1.74e-05	0.000166	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—DPYD—bipolar disorder	1.74e-05	0.000166	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—SLC5A3—bipolar disorder	1.73e-05	0.000165	CbGpPWpGaD
Nefazodone—CYP3A4—Biological oxidations—POMC—bipolar disorder	1.72e-05	0.000164	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—HTR2A—bipolar disorder	1.72e-05	0.000164	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—TRPC3—bipolar disorder	1.71e-05	0.000163	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—HTR2A—bipolar disorder	1.71e-05	0.000163	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—NCAN—bipolar disorder	1.67e-05	0.000159	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—ADM—bipolar disorder	1.67e-05	0.000159	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—CLOCK—bipolar disorder	1.66e-05	0.000158	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—HTR2A—bipolar disorder	1.64e-05	0.000156	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—SLC5A3—bipolar disorder	1.63e-05	0.000156	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—ADM—bipolar disorder	1.63e-05	0.000155	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—TACR1—bipolar disorder	1.62e-05	0.000155	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—TSHB—bipolar disorder	1.62e-05	0.000155	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—PDE4B—bipolar disorder	1.62e-05	0.000155	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—TPH2—bipolar disorder	1.62e-05	0.000154	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—TSHB—bipolar disorder	1.62e-05	0.000154	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—CACNB2—bipolar disorder	1.62e-05	0.000154	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—CACNA1C—bipolar disorder	1.61e-05	0.000154	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—DPYD—bipolar disorder	1.59e-05	0.000152	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—PDE4B—bipolar disorder	1.59e-05	0.000151	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—TSHB—bipolar disorder	1.59e-05	0.000151	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—TACR1—bipolar disorder	1.59e-05	0.000151	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—TRPC3—bipolar disorder	1.59e-05	0.000151	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—ADCY2—bipolar disorder	1.58e-05	0.000151	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—PIK3C2A—bipolar disorder	1.57e-05	0.00015	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—HTR2A—bipolar disorder	1.56e-05	0.000149	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—HTR2A—bipolar disorder	1.55e-05	0.000148	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—HTR1A—bipolar disorder	1.55e-05	0.000147	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—IMPA1—bipolar disorder	1.54e-05	0.000147	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—TAC1—bipolar disorder	1.53e-05	0.000146	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—TAC1—bipolar disorder	1.52e-05	0.000145	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—ADM—bipolar disorder	1.52e-05	0.000144	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—DRD1—bipolar disorder	1.5e-05	0.000143	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—HTR2C—bipolar disorder	1.5e-05	0.000143	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—DRD1—bipolar disorder	1.49e-05	0.000142	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—HTR2A—bipolar disorder	1.49e-05	0.000142	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—HTR1A—bipolar disorder	1.48e-05	0.000141	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—CACNA1C—bipolar disorder	1.48e-05	0.000141	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—PDE4B—bipolar disorder	1.48e-05	0.000141	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—TSHB—bipolar disorder	1.48e-05	0.000141	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—TACR1—bipolar disorder	1.48e-05	0.000141	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—NTRK2—bipolar disorder	1.46e-05	0.000139	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—TAC1—bipolar disorder	1.46e-05	0.000139	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—DRD3—bipolar disorder	1.45e-05	0.000139	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—NTRK2—bipolar disorder	1.45e-05	0.000139	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—HTR2A—bipolar disorder	1.45e-05	0.000138	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—GSK3A—bipolar disorder	1.45e-05	0.000138	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—DRD3—bipolar disorder	1.45e-05	0.000138	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—PIK3C2A—bipolar disorder	1.44e-05	0.000137	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—GSK3A—bipolar disorder	1.44e-05	0.000137	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—DRD1—bipolar disorder	1.43e-05	0.000136	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—HTR2C—bipolar disorder	1.43e-05	0.000136	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—DRD4—bipolar disorder	1.41e-05	0.000135	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—SNAP25—bipolar disorder	1.41e-05	0.000135	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—DRD4—bipolar disorder	1.4e-05	0.000134	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—NTRK2—bipolar disorder	1.39e-05	0.000133	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—DRD3—bipolar disorder	1.39e-05	0.000132	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—GSK3A—bipolar disorder	1.38e-05	0.000131	CbGpPWpGaD
Nefazodone—HTR1A—GPCR downstream signaling—POMC—bipolar disorder	1.37e-05	0.000131	CbGpPWpGaD
Nefazodone—HTR2C—GPCR downstream signaling—POMC—bipolar disorder	1.36e-05	0.00013	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—COMT—bipolar disorder	1.36e-05	0.000129	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—HTR2A—bipolar disorder	1.35e-05	0.000129	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—MAOA—bipolar disorder	1.35e-05	0.000128	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—DRD4—bipolar disorder	1.34e-05	0.000128	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—HTR1A—bipolar disorder	1.34e-05	0.000128	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—ADCY2—bipolar disorder	1.33e-05	0.000127	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—TCF7L2—bipolar disorder	1.32e-05	0.000126	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—TAC1—bipolar disorder	1.32e-05	0.000126	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—ADCY2—bipolar disorder	1.32e-05	0.000126	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—HTR2A—bipolar disorder	1.32e-05	0.000126	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—TCF7L2—bipolar disorder	1.32e-05	0.000126	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—HTR1A—bipolar disorder	1.32e-05	0.000125	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—DRD2—bipolar disorder	1.32e-05	0.000125	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—NDUFV2—bipolar disorder	1.31e-05	0.000125	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—DRD2—bipolar disorder	1.31e-05	0.000125	CbGpPWpGaD
Nefazodone—ADRA1B—GPCR downstream signaling—POMC—bipolar disorder	1.31e-05	0.000125	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—DRD1—bipolar disorder	1.3e-05	0.000124	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—HTR2C—bipolar disorder	1.3e-05	0.000124	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—TAC1—bipolar disorder	1.3e-05	0.000123	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—SNAP25—bipolar disorder	1.29e-05	0.000123	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—DRD1—bipolar disorder	1.27e-05	0.000121	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—HTR2C—bipolar disorder	1.27e-05	0.000121	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—AKR1C4—bipolar disorder	1.27e-05	0.000121	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—ADCY2—bipolar disorder	1.27e-05	0.000121	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—NTRK2—bipolar disorder	1.26e-05	0.00012	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—TCF7L2—bipolar disorder	1.26e-05	0.00012	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—DRD3—bipolar disorder	1.26e-05	0.00012	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—CLOCK—bipolar disorder	1.25e-05	0.000119	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—DRD2—bipolar disorder	1.25e-05	0.000119	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—GSK3A—bipolar disorder	1.25e-05	0.000119	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—ADCY2—bipolar disorder	1.25e-05	0.000119	CbGpPWpGaD
Nefazodone—HTR1A—Signaling by GPCR—POMC—bipolar disorder	1.25e-05	0.000119	CbGpPWpGaD
Nefazodone—HTR2C—Signaling by GPCR—POMC—bipolar disorder	1.24e-05	0.000118	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—NTRK2—bipolar disorder	1.24e-05	0.000118	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—DRD3—bipolar disorder	1.23e-05	0.000117	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—HTR2A—bipolar disorder	1.23e-05	0.000117	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—GSK3A—bipolar disorder	1.22e-05	0.000117	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—HTR1A—bipolar disorder	1.22e-05	0.000116	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—TPH2—bipolar disorder	1.22e-05	0.000116	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—TSHB—bipolar disorder	1.22e-05	0.000116	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—CACNB2—bipolar disorder	1.22e-05	0.000116	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—DRD4—bipolar disorder	1.22e-05	0.000116	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—TAC1—bipolar disorder	1.2e-05	0.000115	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—DPYD—bipolar disorder	1.2e-05	0.000115	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—DRD4—bipolar disorder	1.19e-05	0.000114	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—NTRK1—bipolar disorder	1.19e-05	0.000114	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling by GPCR—POMC—bipolar disorder	1.19e-05	0.000113	CbGpPWpGaD
Nefazodone—HTR2A—GPCR downstream signaling—POMC—bipolar disorder	1.18e-05	0.000113	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—NTRK1—bipolar disorder	1.18e-05	0.000113	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—CLOCK—bipolar disorder	1.18e-05	0.000113	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—HTR2C—bipolar disorder	1.18e-05	0.000113	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—DRD1—bipolar disorder	1.18e-05	0.000113	CbGpPWpGaD
Nefazodone—ADRA1A—GPCR downstream signaling—POMC—bipolar disorder	1.16e-05	0.000111	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—S100B—bipolar disorder	1.16e-05	0.00011	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—S100B—bipolar disorder	1.15e-05	0.00011	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—TSHB—bipolar disorder	1.15e-05	0.00011	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—TPH2—bipolar disorder	1.15e-05	0.00011	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—CACNB2—bipolar disorder	1.15e-05	0.00011	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—ADCY2—bipolar disorder	1.15e-05	0.000109	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—NTRK2—bipolar disorder	1.15e-05	0.000109	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—ADCY2—bipolar disorder	1.14e-05	0.000109	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—TCF7L2—bipolar disorder	1.14e-05	0.000109	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—DRD3—bipolar disorder	1.14e-05	0.000109	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—NR1D1—bipolar disorder	1.14e-05	0.000109	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—GSK3A—bipolar disorder	1.14e-05	0.000108	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—DRD2—bipolar disorder	1.14e-05	0.000108	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—NTRK1—bipolar disorder	1.13e-05	0.000108	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—DPYD—bipolar disorder	1.13e-05	0.000108	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—ADCY2—bipolar disorder	1.12e-05	0.000107	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—TCF7L2—bipolar disorder	1.12e-05	0.000107	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—CACNA1C—bipolar disorder	1.12e-05	0.000106	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—DRD2—bipolar disorder	1.11e-05	0.000106	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—DRD4—bipolar disorder	1.11e-05	0.000106	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—S100B—bipolar disorder	1.1e-05	0.000105	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—MTHFR—bipolar disorder	1.1e-05	0.000104	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—NCAN—bipolar disorder	1.09e-05	0.000104	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—PIK3C2A—bipolar disorder	1.09e-05	0.000104	CbGpPWpGaD
Nefazodone—ADRA2A—GPCR downstream signaling—POMC—bipolar disorder	1.08e-05	0.000103	CbGpPWpGaD
Nefazodone—HTR2A—Signaling by GPCR—POMC—bipolar disorder	1.08e-05	0.000103	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—COMT—bipolar disorder	1.07e-05	0.000102	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—SLC5A3—bipolar disorder	1.07e-05	0.000102	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—MAOA—bipolar disorder	1.06e-05	0.000101	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling by GPCR—POMC—bipolar disorder	1.05e-05	0.0001	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—CACNA1C—bipolar disorder	1.05e-05	0.0001	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—ADCY2—bipolar disorder	1.04e-05	9.96e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—TCF7L2—bipolar disorder	1.04e-05	9.92e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—DRD2—bipolar disorder	1.03e-05	9.85e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—NTRK1—bipolar disorder	1.03e-05	9.81e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—PIK3C2A—bipolar disorder	1.03e-05	9.78e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—NRG1—bipolar disorder	1.02e-05	9.74e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—NRG1—bipolar disorder	1.02e-05	9.69e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—NTRK1—bipolar disorder	1.01e-05	9.6e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—S100B—bipolar disorder	1e-05	9.53e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—COMT—bipolar disorder	9.8e-06	9.34e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—S100B—bipolar disorder	9.79e-06	9.33e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling by GPCR—POMC—bipolar disorder	9.79e-06	9.33e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—SNAP25—bipolar disorder	9.76e-06	9.3e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—MAOA—bipolar disorder	9.73e-06	9.28e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—NRG1—bipolar disorder	9.73e-06	9.28e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—NTRK1—bipolar disorder	9.36e-06	8.92e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—HTR2A—bipolar disorder	9.21e-06	8.78e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—SNAP25—bipolar disorder	9.2e-06	8.77e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—HTR2A—bipolar disorder	9.16e-06	8.74e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—S100B—bipolar disorder	9.1e-06	8.67e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—NRG1—bipolar disorder	8.83e-06	8.41e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—HTR2A—bipolar disorder	8.77e-06	8.36e-05	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—POMC—bipolar disorder	8.77e-06	8.36e-05	CbGpPWpGaD
Nefazodone—CYP3A7—Metabolism—INS—bipolar disorder	8.72e-06	8.31e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—MTHFR—bipolar disorder	8.65e-06	8.24e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—NRG1—bipolar disorder	8.64e-06	8.24e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—ADCY2—bipolar disorder	8.64e-06	8.23e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—ADCY2—bipolar disorder	8.14e-06	7.76e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—NRG1—bipolar disorder	8.03e-06	7.65e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—MTHFR—bipolar disorder	7.92e-06	7.55e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—HTR2A—bipolar disorder	7.79e-06	7.43e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—CLOCK—bipolar disorder	7.72e-06	7.36e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—TSHB—bipolar disorder	7.52e-06	7.17e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—TPH2—bipolar disorder	7.52e-06	7.17e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—CACNB2—bipolar disorder	7.52e-06	7.17e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—GSK3B—bipolar disorder	7.42e-06	7.07e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—DPYD—bipolar disorder	7.4e-06	7.05e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—COMT—bipolar disorder	7.4e-06	7.05e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—GSK3B—bipolar disorder	7.38e-06	7.03e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—POMC—bipolar disorder	7.36e-06	7.01e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—MAOA—bipolar disorder	7.35e-06	7e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—POMC—bipolar disorder	7.32e-06	6.98e-05	CbGpPWpGaD
Nefazodone—HTR1A—Signaling Pathways—INS—bipolar disorder	7.32e-06	6.97e-05	CbGpPWpGaD
Nefazodone—HTR2C—Signaling Pathways—INS—bipolar disorder	7.28e-06	6.94e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—HTR2A—bipolar disorder	7.24e-06	6.9e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—GSK3B—bipolar disorder	7.06e-06	6.73e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—POMC—bipolar disorder	7.01e-06	6.68e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—COMT—bipolar disorder	6.97e-06	6.64e-05	CbGpPWpGaD
Nefazodone—ADRA1B—Signaling Pathways—INS—bipolar disorder	6.97e-06	6.64e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—MAOA—bipolar disorder	6.92e-06	6.6e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—POMC—bipolar disorder	6.92e-06	6.59e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—CACNA1C—bipolar disorder	6.88e-06	6.56e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Metabolism—INS—bipolar disorder	6.88e-06	6.56e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—PIK3C2A—bipolar disorder	6.7e-06	6.39e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—GSK3B—bipolar disorder	6.41e-06	6.11e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—POMC—bipolar disorder	6.36e-06	6.06e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—POMC—bipolar disorder	6.34e-06	6.04e-05	CbGpPWpGaD
Nefazodone—HTR2A—Signaling Pathways—INS—bipolar disorder	6.32e-06	6.03e-05	CbGpPWpGaD
Nefazodone—CYP3A5—Metabolism—INS—bipolar disorder	6.3e-06	6.01e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—GSK3B—bipolar disorder	6.27e-06	5.98e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—POMC—bipolar disorder	6.22e-06	5.93e-05	CbGpPWpGaD
Nefazodone—ADRA1A—Signaling Pathways—INS—bipolar disorder	6.19e-06	5.9e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—SNAP25—bipolar disorder	6.01e-06	5.73e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—MTHFR—bipolar disorder	5.98e-06	5.7e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—GSK3B—bipolar disorder	5.83e-06	5.56e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—POMC—bipolar disorder	5.78e-06	5.51e-05	CbGpPWpGaD
Nefazodone—ADRA2A—Signaling Pathways—INS—bipolar disorder	5.75e-06	5.48e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—MTHFR—bipolar disorder	5.63e-06	5.37e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—ADCY2—bipolar disorder	5.32e-06	5.07e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—POMC—bipolar disorder	4.78e-06	4.56e-05	CbGpPWpGaD
Nefazodone—ABCB1—Metabolism—INS—bipolar disorder	4.76e-06	4.53e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—COMT—bipolar disorder	4.56e-06	4.34e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—MAOA—bipolar disorder	4.53e-06	4.31e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—POMC—bipolar disorder	4.51e-06	4.3e-05	CbGpPWpGaD
Nefazodone—CYP2D6—Metabolism—INS—bipolar disorder	4.48e-06	4.27e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—MTHFR—bipolar disorder	3.68e-06	3.51e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—POMC—bipolar disorder	2.95e-06	2.81e-05	CbGpPWpGaD
Nefazodone—CYP3A4—Metabolism—INS—bipolar disorder	2.93e-06	2.79e-05	CbGpPWpGaD
